Stock A288330 BRIDGE BIOTHERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Bridge Biotherapeutics, Inc.

Equities

A288330

KR7288330004

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 21/06/2024 am IST 		5-day change 1st Jan Change
1,979 KRW -0.35% Intraday chart for Bridge Biotherapeutics, Inc. -16.67% -39.76%
28/03 Bridge Biotherapeutics Launches Research Collaboration with Emory University School of Medicine to Explore Combination Therapy of BBT-877 for KRAS/P53 Mutant NSCLC Patients Resistant to Anti-PD-1 Blockade CI
26/03 Bridge Biotherapeutics Announces Research Collaboration with the University of Colorado School of Medicine to Explore Potential of BBT-877 for Immuno-Oncology CI

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Bridge Biotherapeutics to Present at the 2023 BIO International Convention
AQ
Bridge Biotherapeutics announces preclinical study of self-discovered 4th generation lung cancer targeted therapy at AACR conference in the US
AQ
Bridge Biotherapeutics : Material Management Information related to Judgment of Investment (US FDA approval of BBT-877 phase 2 clinical trial plan for the treatment of Idiopathic Pulmonary Fibrosis (IPF))
PU
Bridge Biotherapeutics : Organization of Investor Relations Event
PU
Bridge Biotherapeutics : Results of issuance(Voluntary Disclosure) (제3자배정-전환우선주)
PU
Bridge Biotherapeutics : Material Management Information related to Judgment of Investment (Bridge Biotherapeutics entered into a License agreement to acquire a preclinical asset to treat fibrotic diseases including Idiopathic Pulmonary Fibrosis (IPF))
PU
Bridge Biotherapeutics : Material Management Information related to Judgment of Investment (Bridge Biotherapeutics entered into an Option to License agreement to acquire a preclinical asset to treat fibrotic diseases including Idiopathic Pulmonary Fibrosis (IPF))
PU
Bridge Biotherapeutics : 30% or More Change in Sales or Profit/Loss(15% or more in the case of large-scale corporations)
PU
Bridge Biotherapeutics : Resolutions for Convocation of General Meeting of Shareholders
PU
Bridge Biotherapeutics : Organization of Investor Relations Event
PU
Bridge Biotherapeutics : Organization of Investor Relations Event
PU
Bridge Biotherapeutics : Closure of Register of Shareholders or Designation of Record Date
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A288330 Stock
  4. News Bridge Biotherapeutics, Inc.
  5. Press Releases